Impact of Data Quality on a Specialty Pharmacy Product Launch

The consequences of not using quality data to support a specialty pharmacy product launch right can be severe – e.g., the entire sales force targeting an incomplete set of physicians or even the wrong physicians. Inaccurate data undermines key initiatives; without a foundation of accurate data governed in an appropriate way, decision-makers lose confidence in the data. Without trusted data, it can be very difficult to move forward on any data project, especially a drug launch.


Clean and consistent data supports more accurate analysis and better decisions. Pharma manufacturers with access to a large, rich, longitudinal set of patient data have a better understanding of patients, crucial for answering business questions and managing marketing and sales efforts during – and after – a specialty pharmacy product launch.

Download the Whitepaper Now

    Company Name
    Tell Us About Your Interest

    By submitting this request, you agree to be added to MSA’s email list. We won’t share your email address with anyone and we won’t ever send you SPAM (per our Privacy Policy)